Deutsche Bank

60 Wall Street
New York
New York
10005-2858
United States

Tel: 212-250-2500
Fax: 212-797-4664

Show jobs for this employer

About Deutsche Bank

Deutsche Bank ranks among the global leaders in corporate banking and securities, transaction banking, asset management, and private wealth management, and has a significant private and business banking franchise in Europe. Deutsche Bank competes to be the leading global provider of financial solutions for demanding clients creating exceptional value for its shareholders and people. With Euro 1,097 billion in assets and 67,474 employees, Deutsche Bank offers unparalleled financial services in 73 countries throughout the world.

Deutsche Bank’s Health Care Investment Banking team is one of the largest and most experienced health care specialist banking groups with approximately 70 professionals worldwide. The group has demonstrated cross-border expertise with unique insights into the global market. They provide for unmatched capital strength along with the ability to rapidly commit significant capital.

The group taps resources across the bank’s integrated platform, including the market’s savviest financing and industry pros. The senior bankers average 16 years of health care investment banking experience and have deep domain expertise in all industry segments and sub-sectors.

Voted the World’s Best Health Care Investment Bank in 2006 by Global Finance, Deutsche Bank is committed to building long-term relationships and providing world-class advisory services for all industry sub-sectors.

Recent landmark life sciences transactions include:

  • Sole financial advisor to Stiefel Laboratories in its $640 million acquisition of Connectics Corporation and sole lead arranger in its $848 million senior secured credit facilities (Pending)
  • Sole book-running manager to United Therapeutics in its $250 million convertible notes offering with call spread (October 2006)
  • Sole financial advisor to Pliva in its $2.5 billion sale to Barr Pharmaceuticals (October 2006)
  • Sole book-running manager to BioMimetic Therapeutics in its $37 million initial public offering (May 2006)
  • Sole book-running manager to Targacept in its $45 million initial public offering (April 2006)
  • Sole book-running manager to Cephalon in its $920 million convertible notes offering with call spread (June 2005)
  • Joint lead-arranger and joint book-running manager in the $3.3 billion debt financing for the LBO of Warner Chilcott by DLJ Merchant Banking Partners, Bain Capital, JPMorgan Partners and Thomas H. Lee Co. (January 2005)

    Contact Information:

    Americas
    Lee Stettner
    New York
    +1(212)250-2084

    Europe
    John Fowler
    London
    +44(20)754-52995

    Transaction information appears as a matter of record only. Deutsche Bank Securities Inc., a subsidiary of Deutsche Bank AG, conducts investment banking and securities activities in the United States. Deutsche Bank Securities Inc., is a member of NYSE, NASD and SIPC. © 2007 Deutsche Bank AG.
    Last Updated: 01-05-2007